Entero Healthcare Solutions profit and loss

Latest FY26

Revenue: ₹6,591cr+29.3% on FY25
EBITDA: ₹266cr+55.0% on FY25
Net profit: ₹146cr+35.7% on FY25
EPS: ₹26.44+21.3% on FY25

₹ crore except per share

Tap a line for its trend	Last 12Mto Jun 2026	FY26Mar 2026	FY25Mar 2025	FY24Mar 2024

Expenses
	7,128	6,591	5,096	3,922
	16.4	19.2	39.5	14.4
	7,144	6,610	5,135	3,937
	6,341	5,915	4,756	3,628
	24.6	−4.0	−147	−57.5
	257	245	199	151
	64.3	54.4	41.6	65.7
	46.7	43.3	30.7	25.0
	192	169	116	89.0
	6,926	6,423	4,997	3,901
	313	266	172	112
	266	223	141	86.8
Profit
	218	188	139	35.6
	−8.2	−8.2	0.0	0.0
	210	179	139	35.6
	69.0	59.5	25.6	13.4
	−26.6	−26.0	5.7	−17.6
	42.4	33.5	31.3	−4.2
	168	146	107	39.8
	168	146	107	39.8
	−0.8	−0.6	0.5	−0.2
	167	145	108	39.6
	125	115	94.8	39.1
	42.3	30.8	12.6	0.7
Per share
	₹28.82	₹26.44	₹21.80	₹10.81
	₹28.78	₹26.40	₹21.76	₹10.81
Other comprehensive income — detail
	−0.8	−0.6	0.5	—
	−1.1	−0.8	0.7	−0.3
	−0.3	−0.2	0.2	—
	—	—	—	−0.0
	125	114	95.2	38.9
	42.2	30.8	12.8	0.7
Per share — as-filed variants
	₹28.82	₹26.44	₹21.80	₹10.81
	₹28.78	₹26.40	₹21.76	₹10.81
Derived — gross profit (revenue − materials − purchases − Δ inventories)
	762	680	486	352
	10.7%	10.3%	9.5%	9.0%
Adjusted (ex-exceptional items) — derived
	218	188	139	35.6
	−8.2	−8.2	0.0	0.0
	174	152	107	39.8
	₹29.94	₹27.65	₹21.80	₹10.81

Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

alphave

ENTERO₹1,559.30

Entero Healthcare Solutions Ltd.

· Consumer Services

Annual Quarterly₹ CrorePeersMEDPLUS EMIL CRIZAC GPPL CMSINFO HEMIPROP BLACKBUCK INOXGREENMcap ₹6,785 Cr

View

In ₹ Crore except Per Share 12 Months Ending	FY23 31/03/2023	FY24 31/03/2024	FY25 31/03/2025	FY26 31/03/2026	Last 12M 30/06/2026
Revenue from Operations	—	3,922.3	5,095.8	6,591.2	7,127.9
Other Income	—	14.4	39.5	19.2	16.4
Total Income	—	3,936.7	5,135.3	6,610.4	7,144.3
Expenses
+ Purchases of Stock-in-Trade	—	3,627.8	4,756.5	5,914.8	6,341.1
+ Changes in Inventories	—	-57.5	-147.0	-4.0	24.6
+ Employee Benefit Expense	—	151.1	199.0	245.5	257.4
+ Finance Costs	—	65.7	41.6	54.4	64.3
+ Depreciation & Amortisation	—	25.0	30.7	43.3	46.7
+ Other Expenses	—	89.0	115.7	168.9	191.9
Total Expenses	—	3,901.2	4,996.5	6,422.9	6,926.0
EBITDA	—	111.8	171.5	266.0	312.9
EBIT	—	86.8	140.9	222.7	266.1
Profit
PBT before Exceptional Items	—	35.6	138.7	187.5	218.3
+ Exceptional Items	—	0.0	0.0	-8.2	-8.2
Pretax Income	—	35.6	138.7	179.3	210.1
+ Current Tax	—	13.4	25.6	59.5	69.0
+ Deferred Tax	—	-17.6	5.7	-26.0	-26.6
Tax Expense	—	-4.2	31.3	33.5	42.4
Net Income	—	39.8	107.4	145.8	167.7
+ Net Income — Continuing Ops	—	39.8	107.4	145.8	167.7
+ Other Comprehensive Income	—	-0.2	0.5	-0.6	-0.8
Total Comprehensive Income	—	39.6	107.9	145.2	166.8
Net Income to Common	—	39.1	94.8	115.0	125.4
Minority Interest	—	0.7	12.6	30.8	42.3
Per Share
Basic EPS	—	10.81	21.80	26.44	28.82
Diluted EPS	—	10.81	21.76	26.40	28.78
Other Comprehensive Income — detail
+ Other Comprehensive Income	—	—	0.5	-0.6	-0.8
+ Items NOT to be Reclassified to P&L	—	-0.3	0.7	-0.8	-1.1
+ Tax on Items NOT to be Reclassified	—	—	0.2	-0.2	-0.3
+ Tax on Items NOT to be Reclassified — alt tag	—	-0.0	—	—	—
Comprehensive Income — Owners of Parent	—	38.9	95.2	114.5	124.6
Comprehensive Income — Non-controlling Interests	—	0.7	12.8	30.8	42.2
Per Share — as-filed variants
Basic EPS — Continuing Operations	—	10.81	21.80	26.44	28.82
Diluted EPS — Continuing Operations	—	10.81	21.76	26.40	28.78
Derived — Gross Profit (Revenue − Materials − Purchases − Δ Inventories)
Gross Profit	—	352.0	486.3	680.4	762.2
Gross Margin %	—	8.97	9.54	10.32	10.69
Adjusted (ex-Exceptional Items) — derived
Pretax Income (Adjusted, as filed)	—	35.6	138.7	187.5	218.3
− Exceptional Items (reconciliation)	—	0.0	0.0	-8.2	-8.2
Net Income Adj (tax-effected)	—	39.8	107.4	152.5	174.2
EPS Adj	—	10.81	21.80	27.65	29.94
Other Filed Concepts — mapped but not yet placed in the schedule
Face Value	—	10.00	10.00	10.00	10.00
Paid Up Equity Capital	—	43.5	43.5	43.5	43.5

As filed, sign as filed — read the label, not the sign. A line appears only when the company tagged that concept in at least one period shown, so depth follows the filer: pre-Ind-AS, insurance and NBFC blocks stay hidden unless they were actually reported. Alternate tags for the same idea (e.g. two spellings of a deferred-tax element) are kept as separate lines rather than merged, because merging them would be a guess. Ratios, per-share figures and counts render as raw numbers, not ₹ Crore. No consensus estimates → no Est columns. Click any row to chart it.

« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave

Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.